Hylke Waalewijn

Major revision version 12.0 of the European <scp>AIDS</scp> Clinical Society guidelines 2023

Juan Ambrosioni, Laura Levi, Jasmini Alagaratnam et al. · HIV Medicine · 2023 · 136 citations · Full text

Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021

Lene Ryom, Rosa de Miguel Buckley, Aoife G. Cotter et al. · HIV Medicine · 2022 · 100 citations · Full text

Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Hylke Waalewijn, Man K. Chan, Pauline Bollen et al. · The Lancet HIV · 2022 · 37 citations · Full text

Treatment And Prevention, Clinical Trials, Pediatrics +6

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Anna Turkova, Hylke Waalewijn, Man K. Chan et al. · The Lancet HIV · 2022 · 23 citations · Full text

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial

Hylke Waalewijn, Alexander J. Szubert, Roeland E. Wasmann et al. · Clinical Infectious Diseases · 2023 · 13 citations · Full text